期刊文献+

原发性肾病综合征患儿CD4^+CD25^+调节性T细胞的变化及临床意义 被引量:4

Change and significance of CD4^+CD25^+ regulatory cells in primary nephrotic syndrome
原文传递
导出
摘要 目的探讨原发性肾病综合征(PNS)患儿外周血淋巴细胞亚群及CD4+CD25+调节性T细胞的变化及其临床意义。方法采用流式细胞术检测23例PNS(肾病组)患儿外周血T淋巴细胞亚群,同时检测17例健康儿童作为对照组。结果 PNS患儿外周血中CD4+CD25+淋巴细胞较正常对照组明显升高(P<0.05)。结论体内异常的CD4+CD25+调节性T细胞水平参与了PNS的发病过程。PNS患儿存在细胞免疫功能紊乱,纠正或调节细胞免疫功能可应用于PNS的临床治疗。 Objective To study the change and clinical significance of T lymphocyte subsets and CD4+CD25+ regulatory T cells in peripheral blood in children with primary nephrotic syndrome(PNS).Methods Peripheral blood T cells from 23 PNS patients and 17 healthy controls were collected,and the T lymphocyte subsets were detected by flow cytometry.Results The proportion of CD4+CD25+ regulatory T cells was higher in PNS patients than that in heathy controls(P0.05).Conclusion The abnormal increase of CD4+CD25+ regulatory T cells in PNS patients may parcitipate in the development of PNS.The cellular immunity in PNS patients is in disorder.Improving the function of cellular immunity may be applied in the clinical treatment of PNS.
出处 《江苏医药》 CAS CSCD 北大核心 2010年第10期1127-1129,共3页 Jiangsu Medical Journal
关键词 原发性肾病综合征 淋巴细胞亚群 CD4+CD25+调节性T细胞 Primary nephrotic syndrome Lymphocyte subsets CD4+CD25+ regulatory T cell
  • 相关文献

参考文献4

  • 1中华医学会儿科学分会肾脏病学组,姚勇,杨霁云,陈述枚,丁洁.小儿肾小球疾病的临床分类、诊断及治疗[J].中华儿科杂志,2001,39(12):746-749. 被引量:1527
  • 2于力,卓美瑛,杨小苏,翁志媛,张又祥.肾病综合征细胞免疫功能动态变化的临床意义[J].实用儿科临床杂志,2001,16(5):274-275. 被引量:2
  • 3Itala M, Aho H, Remes K. Reduced-intensity conditioning and blood stem cell transplantation from an HLA identical sibling for severe aplastic anaemia: two patients with successful engraftment but a fatal post-transplant lymphoproliferative disorder in the other[J].Hematol J, 2004,5 (5):440-443.
  • 4Salama AD, Chaudhry Kathryn AN, Holthaus KA. Regulation by CD25^+ lymphocytes of autoantigen-specific T -cell responses in Goodpasture's (anti-GBM) disease[J].Kidney International, 2003,64(5):1685-1694.

二级参考文献3

共引文献1526

同被引文献53

  • 1张弘,葛宇明,熊保华.原发性小儿肾病综合症血脂变化及其临床意义[J].江汉大学学报(自然科学版),2005,33(2):56-57. 被引量:3
  • 2Imai E, Yokoyama H.Epidemiology of nephrotic syndrome[J].Nihon Jinzo Gakkai shi,2010,52(7):877-881.
  • 3Gordillo R,Spitzer A,The nephrotic syndrome[J].PediatrRev,2009,30(3):94-104.
  • 4王晓玉,李伟.肾病综合征患者免疫功能紊乱研究进展[J].临床医学,2010,23(19):3714-3715.
  • 5Bertelli R?Bodria M,Nobile M,et al.Regulation of innateimmunity by the nucleotide pathway in children with idio-pathic nephrotic syndrome[J].Clin Exp Immunol,2011,166(1):55-63.
  • 6Banaszak B,Banaszak P.The increasing incidence of initialsteroid resistance in childhood nephrotic syndrome [J].Pediatr Nephrol,2012,27(6):927-932.
  • 7Kamei K,Ito S,Nozu K,et al.Single dose of rituximab forrefractory steroid-dependent nephrotic syndrome in chil-dren[J],Pediatr Nephrol,2009,24(7):1321*1328.
  • 8Kim JK,Kim JH,Lee SC,et al.Clinical features and out-comes of IgA nephropathy with nephrotic syndrome[J],Clin J Am Soc Nephrol,2012,7(3):427-436.
  • 9Ulinski T,Aoun B.New treatment strategies in idiopathicnephrotic syndrome [J].Minerva Pediatr,2012,64(2 ):135-143.
  • 10Ali SH,Ali AM,Najim AH.The predictive factors for re- lapses in children with steroid -sensitive nephrotic syn- drome[J].Saudi J Kidney Dis Transpl,2016,27(1):67-72.

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部